Subscribe Now Subscribe Today
Science Alert
 
FOLLOW US:     Facebook     Twitter
Blue
   
Curve Top
International Journal of Pharmacology
  Year: 2006 | Volume: 2 | Issue: 3 | Page No.: 316-319
DOI: 10.3923/ijp.2006.316.319
The First Research Challenge for Diamicron MR in Iranian Diabetic Patients
M. Iranparvar, H.Sadeghi-Bazargani and M. Khodamoradzadeh

Abstract:
The aim of the present study was to test Diamicron`s effectiveness in a group of Iranian patients. In a clinical trial study, 40 diabetic patients which their hyperglycemia was not controlled with diet and exercise were enrolled to take Diamicron MR for a 12 weeks period and their Fasting Plasma Glucose (FPG) and HbA1c measured during treatment. Data were analyzed by SPSS11 statistical package. Repeated measures ANOVA and Paired t tests were used to analyze data . Twenty four persons (60%) were males and 16 of them (40%) were females. The mean for age was 48.8±13.2 (SD) years. FPG in patients before starting drug treatment had a mean of 236.65±75 mg dL-1. Mean of FPG for second week after start of treatment was 180±65 mg dL-1. It was 152±61 mg dL-1 on 4th week and 136±35 mg dL-1 on 8th week. Mean of FPG on 12th weeks was 131±40 mg dL-1. HbA1c was checked both at the beginning of treatment and at the 12th week. Its mean was 11.1±1.9 at the beginning and it was 8.6±1.6 after 12 weeks. The decrease in FPG and HbA1c during the treatment period compared to pretreatment FPG was statistically significant (p<0.01). Diamicron MR was effective in controlling hyperglycemia with a good compliance and less complications in Iranian patients.
PDF Fulltext XML References Citation Report Citation
 RELATED ARTICLES:
  •    Setting the Objectives and Hypotheses in Randomized Clinical Trials: Notices for Clinicians and Pharmacologists
  •    A Test for One-sample Repeated Measures Designs: Effect of High-dimensional Data
  •    Effects of Methyl and Methoxy Derivatives of Phencyclidine on Food and Water Intake
How to cite this article:

M. Iranparvar, H.Sadeghi-Bazargani and M. Khodamoradzadeh , 2006. The First Research Challenge for Diamicron MR in Iranian Diabetic Patients. International Journal of Pharmacology, 2: 316-319.

DOI: 10.3923/ijp.2006.316.319

URL: https://scialert.net/abstract/?doi=ijp.2006.316.319

 
COMMENT ON THIS PAPER
 
 
 

 

 
 
 
 
 
 
 
 
 

 
 
 
 
 
 
 
 
 
 
 

       

       

Curve Bottom